Endpoint Health Inc
CAGE Code: 8L2B3
NCAGE Code: 8L2B3
Status: Active
Type: Commercial Supplier
Summary
Endpoint Health Inc is an Active Commercial Supplier with the Cage Code 8L2B3.
Address
368 University Ave
Los Altos CA 94022-3516
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Biosense Corp Glue-Fold Inc Primex General Imaging Corp Gustayson David B Consultant Jones John Paul And Sons Inc Gustavson David B Netlabs Inc 20/20 Designs, Inc. Moffat Thermosciences Inc Anju Technologies Yaron Consulting Pep-Dom Enterprises Inc Computer Products International Inc G B A Optimal Synthesis Inc Child Evangelism Fellowship Of Erwin Electric Software Maintenance News Inc Teks Electronics Depositions Laboratory
Frequently Asked Questions (FAQ) for CAGE 8L2B3
- What is CAGE Code 8L2B3?
- 8L2B3 is the unique identifier used by NATO Organizations to reference the physical entity known as Endpoint Health Inc located at 368 University Ave, Los Altos CA 94022-3516, United States.
- Who is CAGE Code 8L2B3?
- 8L2B3 refers to Endpoint Health Inc located at 368 University Ave, Los Altos CA 94022-3516, United States.
- Where is CAGE Code 8L2B3 Located?
- CAGE Code 8L2B3 is located in Los Altos, CA, USA.
Contracting History for CAGE 8L2B3 Most Recent 25 Records
- 75A50122C00058
- Endpoint: Gene Expression Scoring Of Immune Activity Levels For Precision Use Of Hydrocortisone In Septic Shock: Secondary Analysis Of The Adrenal Trial Aoi #02: Infection Severity And Solving Sepsis
- 14 Sep 2022
- Endpoint: Gene Expression Scoring Of Immune Activity Levels For Precision Use Of Hydrocortisone In Septic Shock: Secondary Analysis Of The Adrenal Trial Aoi #02: Infection Severity And Solving Sepsis
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $679,115.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00058
- Endpoint: Gene Expression Scoring Of Immune Activity Levels For Precision Use Of Hydrocortisone In Septic Shock: Secondary Analysis Of The Adrenal Trial Aoi #02: Infection Severity And Solving Sepsis
- 17 Jul 2023
- Endpoint: Gene Expression Scoring Of Immune Activity Levels For Precision Use Of Hydrocortisone In Septic Shock: Secondary Analysis Of The Adrenal Trial Aoi #02: Infection Severity And Solving Sepsis
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $679,115.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00058
- Endpoint: Gene Expression Scoring Of Immune Activity Levels For Precision Use Of Hydrocortisone In Septic Shock: Secondary Analysis Of The Adrenal Trial Aoi #02: Infection Severity And Solving Sepsis
- 13 Oct 2023
- Endpoint: Gene Expression Scoring Of Immune Activity Levels For Precision Use Of Hydrocortisone In Septic Shock: Secondary Analysis Of The Adrenal Trial Aoi #02: Infection Severity And Solving Sepsis
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $679,115.00
- Department Of Health And Human Services (Hhs)